![Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/11976c5d-592c-431d-91ff-d611f3edbdb6/gr4_lrg.jpg)
Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development
![Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients - Kidney International Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c997084a-8eb0-47fc-a9c2-719368c32d0b/gr1_lrg.jpg)
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients - Kidney International
![A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients - Kidney International Reports A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8fd89169-1625-494f-9a63-74ddbfabe207/gr1_lrg.jpg)
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients - Kidney International Reports
![Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease - Kidney International Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/34704dbc-3c3b-43b5-b9b3-361a29ab89b0/gr1_lrg.jpg)